Alvotech (ALVO) Cash & Equivalents (2020 - 2026)
Alvotech's (ALVO) quarterly Cash & Equivalents came in at $63.8 million in Q1 2026, up 24.12% YoY from $51.4 million in Q1 2025, and down 62.97% on a QoQ basis from $172.4 million in Q4 2025.
Alvotech (ALVO) Cash & Equivalents (2020 - 2026) Analysis & Trends
Alvotech (ALVO) has 7 years of Cash & Equivalents data on file, last reported at $63.8 million in Q1 2026.
- Quarterly Cash & Equivalents rose 24.12% year-over-year to $63.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $63.8 million (up 24.12% YoY) and the FY2025 annual result came in at $172.4 million, up 235.15% from the prior year.
- Cash & Equivalents declined to $63.8 million in Q1 2026, from $172.4 million in the prior quarter.
- In the past five years, Cash & Equivalents ranged from a high of $172.4 million in Q4 2025 to a low of $10.9 million in Q2 2024.
- A 5-year average of $79.9 million and a median of $64.3 million in 2024 frame the typical range for Cash & Equivalents.
- Annual changes were most pronounced in 2023 — Cash & Equivalents tumbled 83.2% — and 2025, when it surged 1283.88%.
- Tracing ALVO's Cash & Equivalents over 5 years: stood at $66.4 million in 2022, then slumped by 83.2% to $11.2 million in 2023, then surged by 360.95% to $51.4 million in 2024, then soared by 235.15% to $172.4 million in 2025, then sank by 62.97% to $63.8 million in 2026.
- The last three Cash & Equivalents figures came in at $63.8 million (Q1 2026), $172.4 million (Q4 2025), and $51.4 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 1.11 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 3.66 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 1.48 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 2.89 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 1.80 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 886.50 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 332.40 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 164.00 Mn |
| 10 | Alvotech | 1.26 Bn | 1.26 Bn | 5.09 Mn | 63.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 63.83 Mn |
| Dec 31, 2025 | 172.36 Mn |
| Sep 30, 2025 | 51.43 Mn |
| Jun 30, 2025 | 151.45 Mn |
| Mar 31, 2025 | 51.43 Mn |
| Dec 31, 2024 | 51.43 Mn |
| Sep 30, 2024 | 118.27 Mn |
| Jun 30, 2024 | 10.94 Mn |
| Mar 31, 2024 | 64.81 Mn |
| Dec 31, 2023 | 11.16 Mn |
| Jun 30, 2023 | 60.47 Mn |
| Mar 31, 2023 | 115.84 Mn |
| Dec 31, 2022 | 66.43 Mn |
| Jun 30, 2022 | 128.44 Mn |
| Dec 31, 2021 | 17.56 Mn |
| Dec 31, 2020 | 31.69 Mn |